中科微点-全球专利检索

  1. Login
  2. Sign Up
Invention Grant
US09562057B2 (Thieno[2,3-b][1,5]benzoxazepin-4-yl)piperazin-1-yl compounds as dual activity H1 inverse agonists/5-HT2A antagonists 有权
（噻吩并[2,3-b] [1,5]苯并氧氮杂-4-基）哌嗪-1-基化合物作为双重活性H1反向激动剂/ 5-HT2A拮抗剂

  • Patent Title: (Thieno[2,3-b][1,5]benzoxazepin-4-yl)piperazin-1-yl compounds as dual activity H1 inverse agonists/5-HT2A antagonists
  • Patent Title (中): （噻吩并[2,3-b] [1,5]苯并氧氮杂-4-基）哌嗪-1-基化合物作为双重活性H1反向激动剂/ 5-HT2A拮抗剂
  • Application No.: US14758023
    Application Date: 2014-01-08
  • Publication No.: US09562057B2
    Publication Date: 2017-02-07
  • Inventor: Peter Thaddeus Gallagher
  • Applicant: Eli Lilly and Company
  • Applicant Address: US IN Indianapolis
  • Assignee: Eli Lilly and Company
  • Current Assignee: Eli Lilly and Company
  • Current Assignee Address: US IN Indianapolis
  • Agent R. Craig Tucker
  • International Application: PCT/US2014/010577 WO 20140108
  • International Announcement: WO2014/110065 WO 20140717
  • Main IPC: A61K31/553
  • IPC: A61K31/553 ;  C07D498/04
(Thieno[2,3-b][1,5]benzoxazepin-4-yl)piperazin-1-yl compounds as dual activity H1 inverse agonists/5-HT2A antagonists
Abstract:
A dual H1 inverse agonist/5-HT2A receptor antagonist of the formula: its uses, and methods for its preparation are described.
Abstract(Chinese):

描述了下式的双H1逆激动剂/ 5-HT2A受体拮抗剂：[式I]，其用途及其制备方法。

Public/Granted literature
Information query
Espacenet
Patent Agency Ranking
0/0